Report of Foreign Issuer (6-k)
13 February 2018 - 1:39AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 OF
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of February, 2018
Commission
File Number 000-28996
ELBIT
IMAGING LTD.
(Translation
of Registrant’s Name into English)
3
SHIMSHON STREET, PETACH TIKVA, ISRAEL
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
THIS
REPORT ON FORM 6-K IS HEREBY INCORPORATED BY REFERENCE INTO ELBIT IMAGING LTD.’S REGISTRATION STATEMENT ON FORM F-1 (REGISTRATION
STATEMENTS NO. 333-194519), REGISTRATION STATEMENT ON FORM F-3 (REGISTRATION STATEMENT NO. 333-172122) AND REGISTRATION STATEMENTS
ON FORM S-8 (REGISTRATION STATEMENTS NOS. 333-117509, 333-130852, 333-136684 AND 333-152820), AND TO BE A PART THEREOF FROM THE
DATE ON WHICH THIS REPORT IS SUBMITTED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED.
CONTENTS
Elbit
Medical Technologies Ltd. ("
Elbit Medical
"), informed the Company that it published fourth drafts of the relevant
documents for a possible issuance on the Tel Aviv Stock Exchange of a new series of notes convertible into ordinary shares of
Elbit Medical and secured by a lien on a portion of Elbit Medical’s holdings in INSIGHTEC Ltd. and Gamida Cell Ltd.
As
of the date hereof, there is no certainty that Elbit Medical will actually raise debt financing or on what terms. The issuance
of securities by Elbit Medical is subject, among other things, to the existence of appropriate market conditions and receipt of
all approvals required by law, including the approval of Elbit Medical’s Board of Directors and the approval of the Tel
Aviv Stock Exchange and the Israeli Securities Authority.
The
securities being offered by Elbit Medical Technologies Ltd. will not be registered under the U.S. Securities Act of 1933 and will
not be offered or sold in the United States absent registration or an applicable exemption from registration requirements
of the U.S. Securities Act of 1933. This Form 6-K shall not constitute an offer to sell or the solicitation of an offer to buy
any securities.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
ELBIT
IMAGING LTD.
(Registrant)
|
|
|
|
Date:
February 12, 2018
|
By:
|
/s/
Ron Hadassi
|
|
|
Ron
Hadassi
CEO & Chairman of the Board of Directors
|
2
Elbit Imaging (CE) (USOTC:EMITF)
Historical Stock Chart
From Apr 2024 to May 2024
Elbit Imaging (CE) (USOTC:EMITF)
Historical Stock Chart
From May 2023 to May 2024